BETA-GLUCAN IMMUNOTHERAPEUTIC METHODS
This disclosure describes, in one aspect, a method for identifying ²-glucan binding to immune cells of a subject. Generally, the method includes obtaining a blood sample from the subject, the blood sample comprising immune cells, adding soluble ²-glucan to at least a portion of the blood sample and...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | This disclosure describes, in one aspect, a method for identifying ²-glucan binding to immune cells of a subject. Generally, the method includes obtaining a blood sample from the subject, the blood sample comprising immune cells, adding soluble ²-glucan to at least a portion of the blood sample and incubating the mixture under conditions allowing the soluble ²-glucan to bind to the immune cells, and detecting soluble ²-glucan bound to the immune cells. In another aspect, the disclosure describes a method that generally includes identifying the subject as a low binder of ²-glucan, and co-administering to the subject a soluble ²-glucan and an antibody preparation capable of converting the subject from a low binder to a high binder. |
---|